Description

▪ Introduction

Sustanox 250 mg by Novotex Pharma contains Testosterone Sustanon, a medically formulated blend of four testosterone esters: testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, and testosterone decanoate. This combination is designed to provide both rapid onset and sustained testosterone release, making it valuable in testosterone replacement therapy (TRT), androgen deficiency treatments, and related medical research.

In laboratory research, Sustanox 250 mg is studied for its potential role in restoring normal testosterone levels, supporting bone density, maintaining lean body mass, and improving metabolic balance. Manufactured to pharmaceutical standards, each 10 mL multidose vial ensures precise dosage and high purity, strictly for research purposes.

▪ Product Details (Bulleted)

• Active Ingredient: Testosterone Sustanon (blend of four testosterone esters)

• Concentration: 250 mg per mL

• Form: Injectable solution (intramuscular)

• Package Size: 10 × 1 mL ampoules

• Intended Use: Laboratory and analytical use

▪ Pharmacokinetics

Thanks to the ester combination, Sustanon offers both fast-acting and long-acting testosterone release. This allows for administration every 1–3 weeks under research protocols to maintain stable testosterone levels over time.

▪ Usage Recommendations

• Typical Medical/Research Dosage: 250–500 mg every 1–3 weeks in research settings

• Administration Route: Intramuscular injection

• Use Statement: Strictly for laboratory and analytical use only

▪ Disclaimer

This product is strictly for laboratory research use only. It is not approved for human consumption or therapeutic applications. Not intended for individuals under 18, pregnant or breastfeeding women, or those with underlying medical conditions. All research must comply with applicable regulations and ethical standards.